Our study underscores the potential of SGLT2i as preferred therapeutic agents for renal protection in patients with type 2 diabetes, although the potential for a sequential combination with a GLP-1RA remains to be ascertained
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science
Blauvelt: GLP-1 receptor agonists are drugs that have been around, actually, for a long time
Discuss Existing Medical Conditions Inform your doctor about kidney disease, liver disorders, or any ongoing health conditions
GABA accumulates and improves plant resilience to abiotic stress through intracellular pH regulation, ion transport, antioxidant system activation, and ROS scavenging
FDA has stated that compounded drugs that are essentially copies of commercially available approved products may not meet applicable regulatory requirements, and the agency has continued enforcement activity in this area
